Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$160.58
3.192.03%
At close: Dec 15, 4:00 PM EST
$160.58
N/A
After Hours: 4:10 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Repligen (RGEN) stock?
You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.
Who are Repligen (RGEN) competitors?
Other companies in Repligen’s space includes: Medpace Holdings Inc (NASDAQ:MEDP), Agilent Technologies Inc (NYSE:A), Icon PLC (NASDAQ:ICLR), 10x Genomics Inc (NASDAQ:TXG) and BioLife Solutions Inc (NASDAQ:BLFS).
What is the forecast, or price target, for Repligen (RGEN) stock?
Repligen has a consensus price target of $181.72.
What is the current price for Repligen (RGEN)?
The stock price for Repligen (NASDAQ: RGEN) is $160.58 last updated December 15, 2025 at 4:10 PM EST.
Does Repligen (RGEN) pay a dividend?
There are no upcoming dividends for Repligen.
When is Repligen (NASDAQ:RGEN) reporting earnings?
Repligen does not have any upcoming earnings scheduled.
Is Repligen (RGEN) going to split?
There is no upcoming split for Repligen.
What sector and industry does Repligen (RGEN) operate in?
Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
